ACTIVE PHARMA AS: årsregnskap 2022 vs 2021
Shrank 55% on revenue, weaker earnings
approved 2023-07-31; registry 2023-08-02; journal 2023 682732
Summary
What changed
Comparing Årsregnskap 2022 with 2021 for ACTIVE PHARMA AS. Revenue 1.51m NOK → 670.8k NOK (-55.5%). Net result +464.0k NOK → +66.0k NOK. Equity -377.0k NOK → -177.6k NOK.
On the constructive side: equity strengthened; cash rose; payroll decreased. Pressures included: revenue fell; operating result weakened; net result weakened.
Also worth watching: cogs fell. All figures are taken from the published annual accounts for ACTIVE PHARMA AS.
At a glance
Scorecard
What improved
-
↑
Equity strengthened
Book equity -377.0k NOK → -177.6k NOK (equity ratio -173.5% → -144.7%). Calculated
-
↑
Cash rose
Bank deposits 92.4k NOK → 118.9k NOK (+28.7% YoY). Calculated
-
↑
Payroll decreased
Salary cost 625.5k NOK → 420.1k NOK (42% → 63% of revenue). Calculated
What deteriorated
-
↓
Revenue fell
Operating income / revenue moved from 1.51m NOK to 670.8k NOK (-55.5% YoY). Calculated
-
↓
Operating result weakened
Operating result +507.7k NOK → +29.5k NOK (op. margin 33.7% → 4.4%). Calculated
-
↓
Net result weakened
Net result +464.0k NOK → +66.0k NOK (net margin 30.8% → 9.8%). Calculated
Things to notice
-
·
COGS fell
COGS / varekostnad 106.0k NOK → 97.1k NOK (-8.4% YoY). Calculated